Galectin Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Galectin Therapeutics (GALT) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Galectin Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Galectin Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Galectin Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $93k | 22k | 4.24 |
| 2025-03-31 | $13k | 11k | 1.22 |
| 2024-12-31 | $61k | 48k | 1.29 |
| 2024-09-30 | $91k | 33k | 2.75 |
| 2024-06-30 | $51k | 23k | 2.26 |
| 2022-06-30 | $24k | 18k | 1.30 |
| 2022-03-31 | $17k | 11k | 1.58 |
| 2021-12-31 | $23k | 11k | 2.04 |
| 2021-09-30 | $57k | 15k | 3.87 |
| 2021-03-31 | $45k | 21k | 2.16 |
| 2020-12-31 | $52k | 23k | 2.25 |
| 2020-09-30 | $55k | 21k | 2.66 |
| 2020-06-30 | $64k | 21k | 3.08 |
| 2019-12-31 | $92k | 32k | 2.87 |
| 2019-09-30 | $152k | 42k | 3.66 |
| 2019-03-31 | $891k | 174k | 5.11 |
| 2018-12-31 | $48k | 14k | 3.41 |
| 2018-09-30 | $96k | 16k | 6.02 |
| 2017-12-31 | $42k | 13k | 3.35 |
| 2017-09-30 | $30k | 14k | 2.14 |
| 2017-06-30 | $42k | 17k | 2.46 |
| 2017-03-31 | $40k | 17k | 2.30 |
| 2016-12-31 | $15k | 15k | 0.98 |
| 2016-09-30 | $18k | 16k | 1.12 |
| 2016-06-30 | $24k | 16k | 1.44 |
| 2016-03-31 | $734k | 520k | 1.41 |
| 2015-12-31 | $853k | 523k | 1.63 |
| 2015-09-30 | $104k | 45k | 2.33 |
| 2015-06-30 | $133k | 49k | 2.72 |
| 2015-03-31 | $82k | 24k | 3.36 |
| 2014-12-31 | $86k | 25k | 3.49 |
| 2014-03-31 | $816k | 53k | 15.36 |
| 2013-03-31 | $38k | 11k | 3.57 |